Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 24-Jan-24 5:29 PM View:  | Orchard Therapeutics Plc (ORTX) | 24-Jan-24 | Disposition | 44,391 | -- | -- | (100%) 44.39K to 0 | |
| 29-Jun-21 4:15 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 28-Jun-21 | Market Purchase | 10,000 | $9.16 | $91,600.00 | 12% 80.71K to 90.71K | (3%) |
| 05-Apr-21 4:30 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Apr-21 | Grant | 14,773 | $1.32 | $19,500.40 | 14% 104.77K to 119.54K | (13%) |
| 06-Jan-21 4:37 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 04-Jan-21 | Grant | 4,851 | $4.02 | $19,501.00 | 5% 99.92K to 104.77K | (72%) |
| 05-Oct-20 4:06 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Oct-20 | Grant | 8,666 | $2.25 | $19,498.50 | 9% 91.25K to 99.92K | (49%) |
| 02-Jul-20 8:57 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Jul-20 | Grant | 10,894 | $1.79 | $19,500.30 | 14% 80.36K to 91.25K | (36%) |
| 03-Apr-20 5:18 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Apr-20 | Grant | 14,926 | $1.28 | $19,105.30 | 23% 65.43K to 80.36K | (11%) |
| 12-Sep-18 8:49 PM View: | Voyager Therapeutics, Inc. (VYGR) | 10-Sep-18 | Market Purchase | 3,000 | $19.39 | $58,170.00 | 4% 73.59K to 76.59K | (45%) |
| 21-Aug-18 4:05 PM View: | Voyager Therapeutics, Inc. (VYGR) | 17-Aug-18 | Market Purchase | 3,000 | $18.31 | $54,930.00 | 4% 70.59K to 73.59K | (41%) |
| 15-Aug-18 4:31 PM View: | Columbia Laboratories Inc. (JNP) | 14-Aug-18 | Disposition | 80,747 | $11.50 | $928,590.00 | (100%) 80.75K to 0 | 0% |
| 08-Aug-18 7:35 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 07-Aug-18 | Market Purchase | 10,000 | $5.58 | $55,800.00 | 18% 55.43K to 65.43K | (79%) |
| 05-Jul-18 2:53 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 02-Jul-18 | Grant | 8,096 | $1.32 | $10,686.70 | 2% 435.37K to 443.46K | (89%) |
| 16-May-18 9:08 AM View: | Pieris Pharmaceuticals, Inc. (PIRS) | 15-May-18 | Market Purchase | 10,000 | $5.75 | $57,500.00 | 100% 10.0K to 20.0K | (53%) |
| 17-Aug-17 7:20 PM View: | Pieris Pharmaceuticals, Inc. (PIRS) | 17-Aug-17 | Market Purchase | 10,000 | $4.82 | $48,200.00 | 100% 0 to 10.0K | (44%) |
| 05-Jul-17 5:49 PM View: | Columbia Laboratories Inc. (JNP) | 30-Jun-17 | Grant | 15,594 | -- | -- | 24% 65.15K to 80.75K | |
| 05-Jul-17 6:08 PM View: | Columbia Laboratories Inc. (JNP) | 30-Jun-17 | Grant Duplicate | 15,594 | -- | -- | 24% 65.15K to 80.75K | |
| 20-Mar-17 4:46 PM View: | Columbia Laboratories Inc. (JNP) | 17-Mar-17 | Market Purchase | 2,000 | $4.82 | $9,637.40 | 3% 63.15K to 65.15K | 139% |
| 14-Sep-16 5:00 PM View: | Columbia Laboratories Inc. (JNP) | 13-Sep-16 | Market Purchase | 2,000 | $5.97 | $11,930.00 | 3% 61.15K to 63.15K | 93% |
| 24-Aug-16 4:25 PM View: | Columbia Laboratories Inc. (JNP) | 23-Aug-16 | Market Purchase | 2,937 | $6.03 | $17,715.70 | 5% 58.22K to 61.15K | 91% |
| 24-Aug-16 4:25 PM View: | Columbia Laboratories Inc. (JNP) | 22-Aug-16 | Market Purchase | 4,063 | $5.90 | $23,971.70 | 8% 54.15K to 58.22K | 95% |
| 03-Aug-16 8:34 PM View: | Columbia Laboratories Inc. (JNP) | 02-Aug-16 | Grant | 10,613 | -- | -- | 24% 43.54K to 54.15K | |
| 06-Jul-16 5:16 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Jul-16 | Grant | 9,720 | $1.63 | $15,843.60 | 2% 425.65K to 435.37K | (91%) |
| 16-May-16 6:07 AM View: | Idera Pharmaceuticals, Inc. (ACGN) | 13-May-16 | Market Purchase | 10,000 | $1.34 | $13,400.00 | 2% 415.65K to 425.65K | (89%) |
| 19-Nov-15 5:50 PM View: | Columbia Laboratories Inc. (JNP) | 17-Nov-15 | Market Purchase | 8,000 | $11.75 | $94,000.00 | 23% 35.08K to 43.08K | (2%) |
| 30-Oct-15 6:25 PM View: | Columbia Laboratories Inc. (JNP) | 28-Oct-15 | Grant | 2,529 | -- | -- | 8% 32.55K to 35.08K | |
| 10-Aug-15 11:15 AM View: | Columbia Laboratories Inc. (JNP) | 06-Aug-15 | Market Purchase | 12,000 | $10.46 | $125,520.00 | 57% 21.01K to 33.01K | 10% |
| 02-Jun-15 10:58 AM View: | Columbia Laboratories Inc. (JNP) | 01-Jun-15 | Market Purchase | 20,550 | $8.38 | $172,209.00 | (100%) (-20.55K) to 0 | 37% |
| 01-Jun-15 2:46 PM View: | Columbia Laboratories Inc. (JNP) | 26-May-15 | Grant | 461 | $7.51 | $3,462.11 | 100% 0 to 0.46K | 53% |
| 06-Apr-15 4:18 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Apr-15 | Grant | 3,000 | $3.52 | $10,560.00 | < 1% 412.65K to 415.65K | (96%) |
| 29-May-14 4:27 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 27-May-14 | Market Purchase | 10,000 | $2.65 | $26,500.00 | 2% 402.65K to 412.65K | (95%) |
| 03-Apr-14 4:14 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Apr-14 | Grant | 1,636 | $4.41 | $7,214.76 | < 1% 401.01K to 402.65K | (97%) |
| 06-Jan-14 4:13 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 02-Jan-14 | Grant | 1,013 | $4.75 | $4,811.75 | < 1% 400.0K to 401.01K | (97%) |
| 09-Dec-13 5:52 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 06-Dec-13 | Market Purchase | 40,000 | $2.72 | $108,800.00 | 11% 360.0K to 400.0K | (95%) |
| 16-Sep-13 5:21 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 16-Sep-13 | Market Purchase | 60,000 | $1.90 | $114,000.00 | 20% 300.0K to 360.0K | (92%) |
| 20-Aug-13 4:29 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 19-Aug-13 | Market Purchase | 300,000 | $1.75 | $525,000.00 | 100% 0 to 300.0K | (92%) |
| 06-Apr-11 11:44 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 9,750 | $74.00 | $721,500.00 | (66%) 14.71K to 4.96K | (3%) |
| 06-Apr-11 11:44 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 9,750 | -- | -- | 197% 4.96K to 14.71K | |
| 06-Apr-11 11:44 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 4,845 | $74.00 | $358,530.00 | (98%) 4.96K to 0.11K | (3%) |
| 06-Apr-11 11:44 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 112 | $74.00 | $8,288.00 | (100%) 0.11K to 0 | (3%) |
| 15-Jun-10 10:07 AM View: | Genzyme Corp. (GENZ) | 11-Jun-10 | Market Sale | 1,000 | $48.81 | $48,810.00 | (18%) 5.47K to 4.47K | (1%) |
| 26-May-10 4:23 PM View: | Genzyme Corp. (GENZ) | 25-May-10 | Market Option Sale | 2,329 | $45.59 | $106,179.00 | (30%) 7.8K to 5.47K | (12%) |
| 26-May-10 4:23 PM View: | Genzyme Corp. (GENZ) | 24-May-10 | Option Exercise | 5,000 | -- | -- | 179% 2.8K to 7.8K | |
| 05-Jan-10 4:49 PM View: | GTC Biotherapeutics, Inc. (GTCB.OB) | 31-Dec-09 | Grant | 4,000 | $0.75 | $3,000.00 | 26% 15.16K to 19.16K | (53%) |
| 10-Nov-09 10:11 AM View: | Genzyme Corp. (GENZ) | 06-Nov-09 | Option Exercise | 36,875 | $32.52 | $1,199,180.00 | 1497% 2.46K to 39.34K | |
| 10-Nov-09 10:11 AM View: | Genzyme Corp. (GENZ) | 06-Nov-09 | Market Option Sale | 36,875 | $52.07 | $1,920,080.00 | (94%) 39.34K to 2.46K | (< 1%) |
| 28-Sep-09 4:39 PM View: | GTC Biotherapeutics, Inc. (GTCB.OB) | 25-Sep-09 | Grant | 1,564 | $1.76 | $2,749.51 | 12% 13.6K to 15.16K | (80%) |
| 29-Jun-09 6:59 PM View: | GTC Biotherapeutics, Inc. (GTCB.OB) | 26-Jun-09 | Grant | 1,019 | $2.70 | $2,751.30 | 8% 12.58K to 13.6K | (87%) |
| 31-Mar-09 5:07 PM View: | GTC Biotherapeutics, Inc. (GTCB.OB) | 27-Mar-09 | Grant | 8,333 | $0.33 | $2,749.89 | 7% 117.48K to 125.81K | (90%) |
| 29-Dec-08 4:46 PM View: | GTC Biotherapeutics, Inc. (GTCB.OB) | 26-Dec-08 | Grant | 9,874 | $0.28 | $2,749.91 | 9% 107.6K to 117.48K | (88%) |
| 29-Sep-08 4:15 PM View: | GTC Biotherapeutics, Inc. (GTCB.OB) | 26-Sep-08 | Grant | 7,432 | $0.37 | $2,749.84 | 7% 100.17K to 107.6K | (91%) |